2024³â 11¿ù 17ÀÏ ÀÏ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýÈ°

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óÇ°

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Divi¡¯s Laboratories Selects Juniper Networks for Automated Network Infrastructure Across Massive Pharma Manufacturing Facilities

A Juniper-powered network enables Divi's Labs to realize enhanced operational efficiencies and improved network experiences for its workforce of over 17,000 employees
´º½ºÀÏÀÚ: 2023-02-21

HYDERABAD, INDIA-- February 21, 2023 -- Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced that Divi’s Laboratories (NSE: DIVISLAB), one of the largest active pharmaceutical ingredients (API) companies globally, has selected Juniper to deliver highly available, ultra-reliable networking solutions across its manufacturing operations, the largest API manufacturing facilities in the world.

Headquartered in Hyderabad, India, Divi’s Labs strategically partners with many of the world’s leading pharma companies, manufacturing and custom synthesizing APIs for products used in over 95 countries including antidepressants, blood pressure medicine, antihistamines and more. In addition, its nutraceutical division also makes vitamins and beta-carotenes used in supplements, food and beverages sold across the world.

Divi’s currently operates two manufacturing sites which run 24/7 near Hyderabad and Visakhapatnam in India, with a third under construction. Collectively, these operations make up the largest API manufacturing facilities globally, with a gross total of 14,500sqm of manufacturing space spread across over 64 buildings in the two sites.

Due to its stringent quality-control processes, Divi's required an ultra-reliable network that could securely transfer data at line rate between its two plants without any packet loss. After experiencing difficulties managing and monitoring its network with their previous legacy solution, it decided to embark on a network refresh with Juniper that would future-proof several operational requirements.

This network refresh would include reliable Power-over-Ethernet (PoE) and PoE+ switching to drive their wireless infrastructure while providing for organizational-wide network visibility, easy onboarding and manageability. Furthermore, Divi‘s Labs required high-capacity uplinks and multigigabit downlinks to meet growing data exchange needs, as well as the ability to reduce power consumption to meet Divi’s sustainability commitments.

Within each site, Divi’s Labs utilizes the EX4600 as Core/Distribution switches, while EX3400 and EX2300 switches provide connectivity to critical network resources including Wi-Fi Access Points. In addition, their data center also fully runs on Juniper gear, driving critical manufacturing processes like formula management, batch tracking, quality control, compliance tracking and even production scheduling.

Across the network, MACsec encryption on the EX switches provides crucial point-to-point security, while Juniper Virtual Chassis technology has also allowed Divi’s IT teams to swiftly and easily configure, manage and upgrade multiple EX switches as if they were a single device.

The network upgrades from Juniper have provided Divi’s Labs with a highly secure, highly available and ultra-reliable network to continue producing world-class APIs. This is crucial as its business continues to scale up, especially in the pharmaceutical sector where life-saving drugs are created round-the-clock and in which uptime is paramount to ensure the most stringent of quality controls.

For Divi’s Labs, dropped packets and network interruptions are now a thing of the past.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Abu Dhabi Unveils SteerAI, New Tech Venture Set to Transform Industrial Vehicles into Autonomous Powerhouses
Mouser Electronics Examines the Human-Centric Revolution of Industry 5.0
Huons Speeds up Biopharmaceutical Development with Human-Derived Hyaluronidase and Expands Bio-Pharma Business by Acquiring Stake in PanGen
Quectel Accelerates High Precision Positioning With Quadband GNSS Module, Antenna and RTK Correction Service Bundle
ITRS Appoints Ryan Terpstra as CEO
NTT DATA and Google Cloud Expand Strategic Partnership to Accelerate Data Analytics and GenAI Adoption for APAC Enterprises
Public Broadcaster ORF and ORS Group Extend Contract with SES at 19.2 degrees East

 

BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malig...
Uptime Launches Enhanced M&O Stamp of Approval to Accelerate Improveme...
Neutrogena Launches Breakthrough Collaboration with Two of World¡¯s Mo...
Crayon Joins AWS Generative AI Partner Innovation Alliance
Power Integrations Launches 1700 V GaN Switcher IC, Setting New Benchm...
Parse Biosciences Launches Evercode Low Input Fixation for Cells and N...
NetApp Elevates Pamela Hennard to Chief Diversity and Inclusion Office...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚÇ¥±â 'ãæÚ¤ó¢'
´º½º±×·ì Á¤º¸ ¹Ìµð¾î ºÎ¹® »óÇ¥µî·Ï
¾ËÇÁ·Ò °è¿­ »óÇ¥, »óÇ¥µî·Ï ¿Ï·á
¾Ë¶ã°Ç¼³, »óÇ¥µî·Ï ¿Ï·á
Á¸Â÷´åÄÄ, ±Û²Ã º¯°æ »óÇ¥µî·Ï ¿Ï·á

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇÑ°è¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, Æѽº 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..